Durrbach A - Search Results

1

Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper.

Champiat S, Lambotte O, Barreau E, Belkhir R, Berdelou A, Carbonnel F, Cauquil C, Chanson P, Collins M, Durrbach A, Ederhy S, Feuillet S, François H, Lazarovici J, Le Pavec J, De Martin E, Mateus C, Michot JM, Samuel D, Soria JC, Robert C, Eggermont A, Marabelle A. Champiat S, et al. Among authors: durrbach a. Ann Oncol. 2016 Apr;27(4):559-74. doi: 10.1093/annonc/mdv623. Epub 2015 Dec 28. Ann Oncol. 2016. PMID: 26715621 Free article. Review.

2

Association of a POEMS syndrome and light chain deposit disease: first case report.

Lambotte O, Dürrbach A, Ammor M, Paradis V, Djeffal R, Machover D, Charpentier B. Lambotte O, et al. Among authors: durrbach a. Clin Nephrol. 2001 Jun;55(6):482-6. Clin Nephrol. 2001. PMID: 11434361 Review.

3

The long-term effect of switching from cyclosporin A to mycophenolate mofetil in chronic renal graft dysfunction compared with conventional management.

François H, Dürrbach A, Amor M, Djeffal R, Kriaa F, Paradis V, Bedossa P, Charpentier B. François H, et al. Among authors: durrbach a. Nephrol Dial Transplant. 2003 Sep;18(9):1909-16. doi: 10.1093/ndt/gfg250. Nephrol Dial Transplant. 2003. PMID: 12937242

4

New aspect of immunosuppressive treatment in liver transplantation. How could you induce tolerance in liver transplantation?

Beaudreuil S, Samuel D, Rouas-Freiss N, Durrbach A. Beaudreuil S, et al. Among authors: durrbach a. Transpl Immunol. 2007 Feb;17(2):98-107. doi: 10.1016/j.trim.2006.11.007. Epub 2006 Dec 11. Transpl Immunol. 2007. PMID: 17306740 Review.

5

Long-term effects of calcineurin inhibitor conversion to mycophenolate mofetil on renal function after liver transplantation.

Créput C, Blandin F, Deroure B, Roche B, Saliba F, Charpentier B, Samuel D, Durrbach A. Créput C, et al. Among authors: durrbach a. Liver Transpl. 2007 Jul;13(7):1004-10. doi: 10.1002/lt.21170. Liver Transpl. 2007. PMID: 17600361 Free article.

6

Prevention of calcineurin inhibitor nephrotoxicity in renal transplantation.

Jacquet A, Francois H, Frangie C, Ahmad L, Charpentier B, Durrbach A. Jacquet A, et al. Among authors: durrbach a. Transpl Immunol. 2008 Nov;20(1-2):29-31. doi: 10.1016/j.trim.2008.09.002. Epub 2008 Sep 24. Transpl Immunol. 2008. PMID: 18817870

7

IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy.

Jacquet A, Francois H, Frangie C, Yahiaoui Y, Ferlicot S, Micelli C, Mariette X, Durrbach A. Jacquet A, et al. Among authors: durrbach a. Nephrol Dial Transplant. 2009 Nov;24(11):3540-2. doi: 10.1093/ndt/gfp314. Epub 2009 Jun 25. Nephrol Dial Transplant. 2009. PMID: 19556300

8

The blockade of T-cell co-stimulation as a therapeutic stratagem for immunosuppression: Focus on belatacept.

Snanoudj R, Frangié C, Deroure B, François H, Créput C, Beaudreuil S, Dürrbach A, Charpentier B. Snanoudj R, et al. Among authors: durrbach a. Biologics. 2007 Sep;1(3):203-13. Biologics. 2007. PMID: 19707331 Free PMC article.

9

Advances in immunosuppression for renal transplantation.

Durrbach A, Francois H, Beaudreuil S, Jacquet A, Charpentier B. Durrbach A, et al. Nat Rev Nephrol. 2010 Mar;6(3):160-7. doi: 10.1038/nrneph.2009.233. Epub 2010 Feb 2. Nat Rev Nephrol. 2010. PMID: 20125095 Review.

10

Expanding the criteria of renal kidneys for transplantation: use of donors with acute renal failure.

Deroure B, Kamar N, Depreneuf H, Jacquet A, Francois H, Charpentier B, Rostaing L, Durrbach A. Deroure B, et al. Among authors: durrbach a. Nephrol Dial Transplant. 2010 Jun;25(6):1980-6. doi: 10.1093/ndt/gfq009. Epub 2010 Feb 17. Nephrol Dial Transplant. 2010. PMID: 20167568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page